TBC | |||||
Tue23 Mar11:05am(40 mins)
|
|
Dr Mathew Garnett | |||
Session : Functional Genomics
|
Advanced iPSC technologies for neurodegenerative disease research | |||||
Tue23 Mar11:50am(30 mins)
|
![]() |
Michael Ward | |||
Session : Functional Genomics
|
CRISPR/Cas9 - from functional genomics applications to therapeutic genome editing | |||||
Tue23 Mar01:30pm(30 mins)
|
![]() |
Dr Lars Steinmetz | |||
Session : Functional Genomics
|
Screening for functional transcriptional and splicing regulatory variants with GenIE | |||||
Tue23 Mar03:30pm(30 mins)
|
![]() |
Dr Sarah Cooper | |||
Session : Functional Genomics
|
Using CRISPR/Cas9 screens to study epidermal keratinocyte differentiation and inflammation | |||||
Tue23 Mar04:15pm(30 mins)
|
![]() |
Dr Christopher Bryant | |||
Session : Functional Genomics
|
TBC | |||||
Tue23 Mar05:30pm(30 mins)
|
![]() |
Ulrich Elling | |||
Session : Functional Genomics
|
TBC | |||||
Tue23 Mar06:00pm(30 mins)
|
![]() |
Paul Datlinger | |||
Session : Functional Genomics
|
Examining intrinsic and extrinsic regulation of human brain development using cerebral organoids | |||||
Wed24 Mar11:05am(40 mins)
|
![]() |
Dr Madeline Lancaster | |||
Session : Target Validation
|
Deciphering the pathogenicity of cardiac disease-associated genetic variants using human iPSCs and gene editing | |||||
Wed24 Mar11:50am(30 mins)
|
![]() |
Mr Richard Davis | |||
Session : Target Validation
|
Therapeutic strategies via genome engineering: new approaches and new challenges | |||||
Wed24 Mar01:30pm(30 mins)
|
![]() |
Prashant Mali | |||
Session : Target Validation
|
Editing bone marrow stem cells to cure blood disorders | |||||
Wed24 Mar04:00pm(40 mins)
|
![]() |
Prof Jacob Corn | |||
Session : Therapeutics
|
Mechanistic Insights into Cytosine and Adenine Base Editors | |||||
Wed24 Mar05:00pm(30 mins)
|
![]() |
Prof Alexis Komor | |||
Session : Therapeutics
|
TBC | |||||
Wed24 Mar05:45pm(30 mins)
|
![]() |
Manuel Goncalves | |||
Session : Therapeutics
|